Nitric-oxide-dependent systemic immunosuppression in animals with progressively growing malignant gliomas

Area of Science:

• Immunology
• Oncology
• Neuroscience

Background:

• Malignant gliomas are known to induce systemic immunosuppression.
• The precise mechanisms underlying this immunosuppression, particularly the role of spleen cells and nitric oxide (NO), require further elucidation.

Purpose of the Study:

• To analyze the role of NO and adherent spleen cells in systemic immunosuppression in rats with malignant glioma isografts.
• To investigate the impact of NO on immune cell function and cytokine production in the context of glioma.

Main Methods:

• Rats with glioma isografts were immunized with engineered glioma cells.
• Spleen cells were analyzed for immune responsiveness, including cytotoxic activity, proliferation, and cytokine production (IFN-gamma, IL-10).
• The effect of plastic-adherent spleen cells and the NO-synthase inhibitor N-nitro-l-arginine methyl ester were assessed.

Main Results:

• Tumor-bearing rats exhibited decreased NK-cell and T-cell cytotoxic activity and suppressed spleen cell proliferation compared to controls.
• Production of IFN-gamma and IL-10 was significantly reduced in spleen cells from tumor-bearing rats.
• Adherent spleen cells from tumor-bearing rats suppressed immune responses in nonadherent cells, an effect counteracted by NO-synthase inhibition.

Conclusions:

• Systemic immunosuppression in glioma-bearing rats is partly mediated by NO overproduction from adherent spleen cells.
• NO plays a critical role in suppressing immune cell proliferation and cytokine production, contributing to immune evasion by malignant gliomas.